首页 | 本学科首页   官方微博 | 高级检索  
     

重组人肿瘤坏死因子α衍生物治疗鼠脑胶质瘤
引用本文:李涛,李玲莉,李承晏,吴国祥. 重组人肿瘤坏死因子α衍生物治疗鼠脑胶质瘤[J]. 肿瘤防治研究, 2004, 31(1): 1-3
作者姓名:李涛  李玲莉  李承晏  吴国祥
作者单位:1. 430060,武汉大学人民医院神经内科
2. 430060,武汉大学人民医院急诊科
基金项目:湖北省科技厅自然科学基金
摘    要: 目的 探讨重组人肿瘤坏死因子α衍生物 (rhTNF α)治疗鼠脑胶质瘤的有效性。方法 通过改造人肿瘤坏死因子α形成rhTNF α ,体外培养鼠脑胶质瘤细胞 ,加入不同浓度rhTNF α,MTT法测定细胞存活率 ,颅内立体定向种植C6细胞制成鼠脑胶质瘤模型 ,10天后MRI增强测量肿瘤大小 ,腹腔注射rhTNF α ,治疗后第 8天、15天、2 1天分别用MRI增强测量肿瘤大小。结果 体外实验 :加入rhTNF α 5天后 ,大部分C6细胞死亡 ,细胞存活率随rhTNF α的递增而降低。体内实验 ,治疗 8天后肿瘤即开始缩小 ,治疗 2 1天后 ,MRI未见明显肿瘤强化灶。结论 rhTNF α能有效治疗鼠脑胶质瘤。

关 键 词:重组人肿瘤坏死因子  α衍生物  治疗  胶质瘤
文章编号:1000-8578(2004)01-0001-03
收稿时间:2003-06-02
修稿时间:2003-06-02

Derivative of recombinant human tumor necrosis factor-α therapy for rat glioma
LI Tao,LI Ling-li,LI Cheng-yan,et al Renming hospital of Wuhan University,Wuhan ,China. Derivative of recombinant human tumor necrosis factor-α therapy for rat glioma[J]. Cancer Research on Prevention and Treatment, 2004, 31(1): 1-3
Authors:LI Tao  LI Ling-li  LI Cheng-yan  et al Renming hospital of Wuhan University  Wuhan   China
Affiliation:LI Tao,LI Ling-li,LI Cheng-yan,et al Renming hospital of Wuhan University,Wuhan 430060,China
Abstract:Objective To investigate the effects of derivative of recombinant human tumor necrosis factor-α(rhTNF-α) therapy for rat glioma. Methods rhTNF-α were created by modifying TNF-α, were cultured in culture medium conclude rhTNF-α in different concertration. The livability of cells was determined by MTT technique five days later and implanted C 6 cells in rat s brain to establish glioma model. rhTNF-α were intraperitoneally injected 10 days after implanted. The volume of glioma were measured by MRI 10 days a...
Keywords:rhTNF-α  Therapy  Glioma
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号